Medicaid can cover testosterone replacement therapy, but there is no single national rule that guarantees it. Prescription drug coverage is technically an optional Medicaid benefit that every state has chosen to offer (KFF, 5 Key Facts About Medicaid Prescription Drugs), and each state runs its own preferred drug list and prior authorization rules for testosterone. In practice, that means coverage depends less on whether you have Medicaid and more on which state's Medicaid program you're enrolled in, and whether your labs support a diagnosis the program will pay to treat.
Why Medicaid TRT coverage isn't the same in every state
Medicaid is a joint federal-state program, and while the federal government sets baseline requirements, each state administers its own pharmacy benefit within those rules. States build their own preferred drug lists (PDLs), which steer prescribers toward the cheapest covered option, and layer prior authorization on top of drugs that fall outside that list (KFF, 5 Key Facts About Medicaid Prescription Drugs). For a widely prescribed generic like testosterone cypionate, that usually means the injectable form is on the preferred list in most states, while gels, patches, and newer formulations are more likely to require extra paperwork or a documented reason a generic injection won't work.
Some states also carve pharmacy benefits out of managed care and run them fee-for-service, while others hand the entire pharmacy benefit to a managed care organization's own formulary. Either way, the practical result is the same: two men with Medicaid in two different states, both with confirmed low testosterone, can face very different approval timelines and out-of-pocket costs.
What Medicaid programs typically require to approve TRT
Where Medicaid programs cover testosterone, they almost always tie approval to the same diagnostic standard used by commercial insurers and the Endocrine Society's clinical practice guideline: documented symptoms of low testosterone plus low levels confirmed on morning bloodwork, not a single test or a symptom checklist alone (Bhasin S, et al., Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab, 2018). A prior authorization request that skips the labs, or relies on a single afternoon draw, is one of the most common reasons a Medicaid claim gets kicked back for more documentation.
Many state programs also draw a distinction between classical hypogonadism, caused by a specific medical condition like pituitary disease, testicular injury, or a genetic condition such as Klinefelter syndrome, and age-related decline in testosterone that isn't tied to a diagnosable cause. Programs are generally more willing to approve treatment for the former, and some restrict or exclude coverage for testosterone prescribed for age-related decline alone.
Does Medicaid cover TRT from a telehealth clinic?
It depends on the state, not on telehealth itself. Most state Medicaid programs cover legitimate telehealth visits the same way they cover in-person ones, but the testosterone prescription still has to clear that state's pharmacy prior authorization process regardless of whether the diagnosing visit happened online or in an office. Where telehealth TRT clinics run into trouble with Medicaid isn't the visit format, it's that many cash-pay telehealth programs don't bill insurance at all, and a clinic that only accepts self-pay won't submit a claim to Medicaid even if your coverage would otherwise apply. If cost is the deciding factor, it's worth confirming upfront whether a clinic bills Medicaid directly or expects payment out of pocket before you start the intake process.
What to do if your state Medicaid plan denies TRT coverage
A denial isn't always the final word. Start by asking your provider's office for the specific reason listed on the denial, since it's often a documentation gap, like a missing second lab draw or a diagnosis code that doesn't match the program's criteria, rather than a blanket exclusion. Every state Medicaid program has an appeals process, and resubmitting a prior authorization with the correct morning labs and a clear diagnosis clears more denials than most patients expect. If your case still doesn't qualify under Medicaid's criteria, it's reasonable to ask your provider about lower-cost cash-pay options or compare clinics that offer sliding-scale or bundled monthly pricing, since testosterone cypionate itself is inexpensive even without insurance.
If you're navigating this process and want to compare providers who work with a range of payment situations, you can browse TRT clinics in California, a state with one of the country's largest Medicaid populations, or search the full TRT Locator directory to find a clinic near you.
